HOME >> MEDICINE >> NEWS
The Starr Foundation launches multi-institutional cancer consortium

billion, has donated in excess of $2 billion more than $1 billion in New York City alone making it one of the largest private foundations in the United States. The Foundation supports education, cultural institutions, medicine and healthcare, human needs, public policy, and the environment.

Each institution taking part in the Starr Cancer Consortium enjoys international distinction as a leader in scientific research and discovery. At the same time, they have each compiled an impressive track record of collaborative work in a variety of partnerships. The Starr Foundation grant of $100 million will be earmarked specifically for joint projects involving two or more institutions, including several highly promising initiatives already underway.

Key areas of focus for the Starr Cancer Consortium will include:

  • Creation or accelerated development of powerful technology platforms designed to unravel the genetic and molecular basis of cancers

  • Application of these technologies in joint projects aimed at developing new and highly effective approaches to diagnosis and treatment

  • Support for basic biological research to provide insights into the fundamental molecular and cellular processes underlying cancer

Activities selected for funding through the Starr Cancer Consortium will be determined by an executive committee including leaders of the five institutions: Eric Lander of the Broad Institute of MIT and Harvard, Bruce Stillman of Cold Spring Harbor Laboratory, Harold Varmus of Memorial Sloan-Kettering Cancer Center, Paul Nurse of The Rockefeller University and Antonio M. Gotto, Jr., of Weill Cornell Medical College.

Inspired by The Starr Foundation's visionary generosity in establishing the Starr Cancer Consortium, the five collaborating institutions (profiled below) are committed to achieving dramatic progress in addressing the enormous challenges posed by cancer and in seizing one
'"/>

Contact: Jill Totenberg
jtotenberg@totenberggroup.com
212-994-7363
Memorial Sloan-Kettering Cancer Center
21-Sep-2006


Page: 1 2 3 4

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. The Eli and Edythe Broad Foundation invests in gastroenterologys future
3. Dyson Foundation gives $5 Million for ophthalmology research at Weill Cornell Medical College
4. Rosenzweig to head Leducq Foundation cardiovascular research grant
5. UCSF pharmacy school receives major grant from Amgen Foundation for Medicare Part D outreach
6. Woodruff Foundation gives major boost to Emory Universitys strategic plan
7. Rockefeller Foundation will not abandon its commitments to public health
8. Hartford Foundation awards grant to address geriatric social work shortage
9. Clinton Foundation joins efforts in the fight against AIDS in Ukraine
10. UTSA receives $225,000 National Science Foundation grant to support doctoral students in physics
11. NDRI receives Josiah Macy, Jr. Foundation grant

Post Your Comments:
(Date:1/23/2015)... AZ (PRWEB) January 23, 2015 Hastings and ... injury matters, reports a record number of legal representation client ... speaking, there has been a steady rise in the number ... work and at home throughout the Valley. With that said, ... accident be reviewed by an experienced law firm. Hastings and ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
(Date:1/23/2015)... 23, 2015  MedScope ( www.medscope.org ), the leading provider ... 2015 Connected World magazine Connected World Award ... that can be used anywhere, anytime. The nomination was ... In nominating MedScope, Landon Garner , Director ...
(Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: